Bagholders_Anonymous2 days agoSRPT FDA approved resuming Elevidys treatment for ambulatory patients, unfavorable FDA boss ousted. Depending on earnings and future guidance this may see a decent rebound.
Bagholders_AnonymousJul 22SRPT "Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S." 7/22/25